Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Hamilton Thorne Ltd. (V:HTL)

Business Focus: Advanced Medical Equipment & Technology

INK Edge Outlook

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for HTL within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Oct 13, 2021 16:47 ET
Hamilton Thorne Equity Grants Under Its Long-Term Equity Incentive Plan
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it has issued incentive...
Read full article
Aug 18, 2021 08:15 ET
Hamilton Thorne Reports Financial and Operational Results for the Quarter-Ended June 30, 2021
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported unaudited financial and...
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
1.02
--
--
Price to Sales - TTM
4.52
23.08
12.53
Price to Book - most recent quarter
3.91
4.40
3.18
Price to Cash Flow per share - TTM
36.90
36.90
13.64
Price to Free Cash Flow per share - TTM
26.72
80.07
32.93
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Sep 30, 202112,930221
Sep 15, 202112,709-34,652
Aug 31, 202147,36140,443
See Short Report

Business Summary

Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology

Hamilton Thorne Ltd. provider of precision instruments, consumables, software and services to the assisted reproductive technologies (ART), animal breeding, stem cell, and developmental biology research markets. The Company's products lines include precision laser devices, imaging systems, micromanipulation systems, air purification systems, incubators, control rate freezers, and lab monitoring systems. Its GM501 product provides the In Vitro Fertilization (IVF)lab with a cell culture media solution, including oocyte handling, sperm processing, embryo culture, and cryopreservation. Its services offers a range of user needs, ranging from equipment service contract and maintenance programs, quality control testing services to manufacturers of medical devices, culture media and consumables used in IVF labs, and laboratory design and installation services. The Company's brands include Hamilton Thorne, Gynemed, Planer, IVFtech, Embryotech Laboratories, and Tek-Event.

See business summary

 

Twitter

Search (past week) for $HTL.CA HTL.V